Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects

Plain-language summary

This study aims to build a diagnostic and prognostic database of variant effects in people carrying mutations in the KCNH2 gene. Patients who carry a mutation in the KCNH2 gene can take part. It has no assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Nantes University Hospital

Start date

9/20/2021

Estimated completion

3/24/2026

Countries

France

Related genes

Locations

• Nantes, France
• Paris, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients carrier of a mutation in KCNH2 gene

Exclusion Criteria:

* Patients who refuse to take part to research